Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuetie Dingchuan Ointment is a Traditional Chinese Medicine (TCM) topical preparation developed by the Nanjing University of Chinese Medicine for the treatment of bronchial asthma. It is primarily utilized in acupoint application therapy (Xue-wei Tie-fu), a method where the ointment is applied to specific acupuncture points (such as BL13/Feishu and GV14/Dazhui) to achieve therapeutic effects. The formulation typically contains herbal ingredients like *Semen Sinapis*, *Corydalis Rhizoma*, *Euphorbia kansui*, and *Asari Radix et Rhizoma*. Its mechanism of action involves the transdermal absorption of active herbal components and the stimulation of acupoints, which together modulate the immune response (e.g., balancing Th1/Th2 cytokines), reduce airway hyperresponsiveness, and alleviate chronic airway inflammation. It is frequently used in "winter disease summer treatment" protocols to prevent asthma exacerbations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xuetie Dingchuan Ointment.